Your browser doesn't support javascript.
loading
High pulse pressure is a risk factor for prodromal Alzheimer's disease: a longitudinal study.
Shi, Wen-Yan; Wang, Zuo-Teng; Sun, Fu-Rong; Ma, Ya-Hui; Xu, Wei; Shen, Xue-Ning; Dong, Qiang; Tan, Lan; Yu, Jin-Tai; Yu, Yang.
Afiliación
  • Shi WY; Department of Neurology, Qingdao Municipal Hospital, Dalian Medical University, Dalian, China.
  • Wang ZT; College of Medicine and Pharmaceutics, Ocean University of China, Qingdao, China.
  • Sun FR; Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China.
  • Ma YH; Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China.
  • Xu W; Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China.
  • Shen XN; Department of Neurology and Institute of Neurology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
  • Dong Q; Department of Neurology and Institute of Neurology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
  • Tan L; Department of Neurology, Qingdao Municipal Hospital, Dalian Medical University, Dalian, China.
  • Yu JT; College of Medicine and Pharmaceutics, Ocean University of China, Qingdao, China.
  • Yu Y; Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China.
Aging (Albany NY) ; 12(18): 18221-18237, 2020 Sep 22.
Article en En | MEDLINE | ID: mdl-32960784
ABSTRACT
It has been increasingly evident that pulse pressure (PP) is associated with Alzheimer's disease (AD) but whether PP increases AD risk and the mechanism responsible for this association remains unclear. To investigate the effects of PP in the process of AD, we have evaluated the cross-sectional and longitudinal associations of PP with AD biomarkers, brain structure and cognition and have assessed the effect of PP on AD risk in a large sample (n= 1,375) from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Multiple linear regression and mixed-model regression were employed in cross-sectional and longitudinal analyses respectively. Clinical disease progression was assessed using Cox proportional hazards models. High PP was associated with lower ß-amyloid 42 (Aß42) (P= .015), and higher total tau (T-tau) (P= .011), phosphorylated tau (P-tau) (P= .003), T-tau/Aß42 (P= .004) and P-tau/Aß42 (P = .001), as well as heavier cortical amyloid-beta burden (P= .011). Longitudinally, baseline high PP was significantly associated with hippocampal atrophy (P= .039), entorhinal atrophy (P= .031) and worse memory performance (P= .058). Baseline high PP showed more rapid progression than those with normal PP (P <.001). These results suggest PP elevation could increase AD risk, which may be driven by amyloid plaques and subclinical neurodegeneration.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Aging (Albany NY) Asunto de la revista: GERIATRIA Año: 2020 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Aging (Albany NY) Asunto de la revista: GERIATRIA Año: 2020 Tipo del documento: Article País de afiliación: China